Equities

NaturalShrimp Inc

SHMP:QBB

NaturalShrimp Inc

Actions
  • Price (USD)0.0111
  • Today's Change-0.001 / -6.72%
  • Shares traded1.33m
  • 1 Year change-71.90%
  • Beta1.6465
Data delayed at least 15 minutes, as of Apr 26 2024 20:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NaturalShrimp Incorporated is a biotechnology aquaculture company. The Company has developed a commercially viable system for growing shrimp in enclosed salt-water systems using technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Its systems can be located anywhere to produce gourmet-grade Pacific white shrimp. Its Vibrio Suppression technology utilizes electrocoagulation (a procedure that uses heat from an electric current to destroy abnormal tissue) to kill potential pathogens and harmful bacteria, such as vibrio. The Company's technology platforms combine electrocoagulation and Hydrogas. The electrocoagulation system replaces the need for biofilters and instead applies non-biological, electrical processes and uses electronics to remove ammonia and to control the level of pathogens in an aquaculture system. Its subsidiaries include NaturalShrimp USA Corporation, NaturalShrimp Global, Inc., and Natural Aquatic Systems, Inc.

  • Revenue in USD (TTM)417.86k
  • Net income in USD-15.32m
  • Incorporated2008
  • Employees28.00
  • Location
    NaturalShrimp Inc13601 PRESTON RD., E1092DALLAS 75240United StatesUSA
  • Phone+1 (702) 350-8132
  • Fax+1 (608) 827-5501
  • Websitehttps://naturalshrimp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Inspire Veterinary Partners Inc16.68m-15.06m3.76m156.00------0.2254-1.93-1.931.73-0.07210.794522.7549.42106,893.60-70.48---108.99--21.31---88.71--0.103-2.831.05--69.56---206.68------
Aquabounty Technologies Inc2.47m-27.56m7.52m104.00--0.0455--3.04-7.43-7.430.667442.890.01237.62--23,775.58-13.73-14.40-14.84-15.10-518.02-603.67-1,114.50-1,432.140.6796-89.870.049---21.1896.45-24.37--75.78--
NaturalShrimp Inc417.86k-15.32m11.59m28.00------27.74-0.0165-0.01650.0005-0.0070.01384.6235.0814,923.57-48.67-158.69-72.20-388.0222.24---3,537.60-43,270.050.0275-2.971.32--606.81--81.84--71.64--
Nocera Inc26.31m-4.32m15.42m10.00--2.09--0.5861-0.4665-0.46652.760.57012.96172.7661.69---48.26-61.35-74.51-109.121.1715.42-16.32-44.101.31--0.08--64.29--49.96------
Data as of Apr 26 2024. Currency figures normalised to NaturalShrimp Inc's reporting currency: US Dollar USD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
WoodTrust Asset Management, NAas of 31 Mar 2024150.00k0.01%
Virtue Capital Management LLCas of 31 Dec 20230.000.00%
Cullinan Associates, Inc.as of 31 Mar 20240.000.00%
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.